Lars Gille

Dr. Lars Gille

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
Andrey KozlovAndrey Kozlov
Andrey Kozlov
SBSoheyl Bahrami
Soheyl Bahrami
ECEnrico Calzia
Enrico Calzia
PDPeter Dungel
Peter Dungel
LGLars Gille
Lars Gille
Jakob TroppmairJakob Troppmair
Jakob Troppmair
Mitochondrial functions include production of energy, activation of programmed cell death, and a number of cell specific tasks, e.g., cell signaling, control of Ca2+ metabolism, and synthesis of a number of important biomolecules. As proper mitochondrial function is critical for normal performance and survival of cells, mitochondrial dysfunction often leads to pathological conditions resulting in various human diseases. Recently mitochondrial dysfunction has been linked to multiple organ failure (MOF) often leading to the death of critical care patients. However, there are two main reasons why this insight did not generate an adequate resonance in clinical settings. First, most data regarding mitochondrial dysfunction in organs susceptible to failure in critical care diseases (liver, kidney, heart, lung, intestine, brain) were collected using animal models. Second, there is no clear therapeutic strategy how acquired mitochondrial dysfunction can be improved. Only the benefit of such therapies will confirm the critical role of mitochondrial dysfunction in clinical settings. Here we summarized data on mitochondrial dysfunction obtained in diverse experimental systems, which are related to conditions seen in intensive care unit (ICU) patients. Particular attention is given to mechanisms that cause cell death and organ dysfunction and to prospective therapeutic strategies, directed to recover mitochondrial function. Collectively the data discussed in this review suggest that appropriate diagnosis and specific treatment of mitochondrial dysfunction in ICU patients may significantly improve the clinical outcome.

19 April 2018 in Phytotherapy Research
Verified
Journal Article
Open access
PDF file
LMLianet Monzote
Lianet Monzote
GGGerald Geroldinger
Gerald Geroldinger
MTMatthias Tonner
Matthias Tonner
RSRamón Scull
Ramón Scull
SSSritama De Sarkar
Sritama De Sarkar
LGLars Gille
Lars Gille
The antileishmanial activity of the essential oil (EO) fromChenopodium ambrosioidesL. has been demonstrated in vitro and in animal models, attributed to the major components of the EO. This study focused on the effects of the three major EO compounds carvacrol, caryophyllene oxide (Caryo), and the antileishmanial endoperoxide ascaridole (Asc) on mitochondrial functions inLeishmania tarentolaepromastigotes (LtP). EO and Caryo were able to partially inhibit the leishmanial electron transport chain, whereas other components failed to demonstrate a direct immediate effect. Caryo demonstrated inhibition of complex III activity in LtP and in isolated complex III from other species. The formation of superoxide radicals was studied inLeishmaniaby electron spin resonance spectroscopy in the presence of iron chelators wherein selected compounds failed to trigger a significant immediate additional superoxide production in LtP. However, upon prolonged incubation ofLeishmaniawith Asc and especially in the absence of iron chelators (allowing the activation of Asc), an increased superoxide radical production and significant impairment of mitochondrial coupling inLeishmaniawas observed. Prolonged incubation with all EO components resulted in thiol depletion. Taken together, the major components of EO mediate their leishmanicidal activity via different mitochondrial targets and time profiles. Further studies are required to elucidate possible synergistic effects of carvacrol and Asc and the influence of minor compounds.

25 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
LMLianet Monzote
Lianet Monzote
Alexander ScherbakovAlexander Scherbakov
Alexander Scherbakov
RSRamón Scull
Ramón Scull
Prabodh SatyalPrabodh Satyal
Prabodh Satyal
PCPaul Cos
Paul Cos
William N. SetzerWilliam N. Setzer
William N. Setzer
Essential oils (EOs) are known for their use in cosmetics, food industries, and traditional medicine. This study presents the chemical composition and therapeutic properties against kinetoplastid and eukaryotic cells of the EO from Melaleucaleucadendra (L.) L. (Myrtaceae). Forty-five compounds were identified in the oil by GC-MS, containing a major component the 1,8-cineole (61%). The EO inhibits the growth of Leishmania amazonensis and Trypanosoma brucei at IC50 values <10 μg/mL. However, 1,8 cineole was not the main compound responsible for the activity. Against malignant (22Rv1, MCF-7, EFO-21, including resistant sublines MCF-7/Rap and MCF-7/4OHTAMO) and non-malignant (MCF-10A, J774A.1 and peritoneal macrophage) cells, IC50 values from 55 to 98 μg/mL and from 94 to 144 μg/mL were obtained, respectively. However, no activity was observed on Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Aspergillus niger, Candida parapsilosis, Microsporum canis, or Trypanosoma cruzi. The EO was able to control the lesion size and parasite burden in the model of cutaneous leishmaniasis in BALB/c mice caused by L. amazonensis compared to untreated animals (p < 0.05) and similar with those treated with Glucantime® (p > 0.05). This work constitutes the first evidence of antiproliferative potentialities of EO from M. leucadendra growing in Cuba and could promote further preclinical investigations to confirm the medical value of this plant, in particular for leishmaniasis treatment.

1 May 2017 in Biochemical Pharmacology
Verified
Journal Article
Closed access
GGGerald Geroldinger
Gerald Geroldinger
MTMatthias Tonner
Matthias Tonner
HHHubert Hettegger
Hubert Hettegger
MBMarkus Bacher
Markus Bacher
LMLianet Monzote
Lianet Monzote
LGLars Gille
Lars Gille

5 November 2018 in Parasitology
Verified
Journal Article
Closed access
PDF file
SSSritama De Sarkar
Sritama De Sarkar
DSDeblina Sarkar
Deblina Sarkar
ASAvijit Sarkar
Avijit Sarkar
ADAishwarya Dighal
Aishwarya Dighal
SCSasanka Chakrabarti
Sasanka Chakrabarti
MCMitali Chatterjee
Mitali Chatterjee
Endoperoxides kill malaria parasitesviacleavage of their endoperoxide bridge by haem or iron, leading to generation of cytotoxic oxygen-centred radicals. In view of theLeishmaniaparasites having a relatively compromised anti-oxidant defense and high iron content, this study aims to establish the underlying mechanism(s) accounting for the apoptotic-like death ofLeishmaniapromastigotes by artemisinin, an endoperoxide. The formation of reactive oxygen species was confirmed by flow cytometry and was accompanied by inhibition of mitochondrial complexes I–III and II–III. However, this did not translate into a generation of mitochondrial superoxide or decrease in oxygen consumption, indicating minimal impairment of the electron transport chain. Artemisinin caused depolarization of the mitochondrial membrane along with a substantial depletion of adenosine triphosphatase (ATP), but it was not accompanied by enhancement of ATP hydrolysis. Collectively, the endoperoxide-mediated radical formation by artemisinin inLeishmaniapromastigotes was the key step for triggering its antileishmanial activity, leading secondarily to mitochondrial dysfunction indicating that endoperoxides represent a promising therapeutic strategy againstLeishmaniaworthy of pharmacological consideration.

1 May 2006 in Biochemical Pharmacology
Verified
Journal Article
Closed access
WGWolfgang Gregor
Wolfgang Gregor
KSKatrin Staniek
Katrin Staniek
HNHans Nohl
Hans Nohl
LGLars Gille
Lars Gille